The risk or severity of adverse effects can be increased when mecamylamine is combined with losartan.


The risk or severity of adverse effects can be increased when nystatin is combined with manidipine.


The risk or severity of adverse effects can be increased when Naftifine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with felodipine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with HEROIN.


The risk or severity of adverse effects can be increased when nystatin is combined with cilnidipine.


The risk or severity of adverse effects can be increased when nystatin is combined with Benidipine.


The risk or severity of adverse effects can be increased when nystatin is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Nebivolol.


The risk or severity of adverse effects can be increased when trazodone is combined with bromocriptine.


The risk or severity of adverse effects can be increased when nystatin is combined with Efonidipine.


The risk or severity of adverse effects can be increased when quazepam is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when cocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when Ruxolitinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when Lurasidone is combined with topiramate.


The risk or severity of adverse effects can be increased when sulindac is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Asenapine is combined with enflurane.


The risk or severity of adverse effects can be increased when pramipexole is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when hydromorphone is combined with methazolamide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when Etidocaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when procarbazine is combined with clozapine.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with meperidine.


The risk or severity of adverse effects can be increased when trandolapril is combined with floctafenine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with amisulpride.


The risk or severity of adverse effects can be increased when imipramine is combined with atenolol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with triflupromazine.


The risk or severity of adverse effects can be increased when ketamine is combined with Retigabine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when valsartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when lisinopril is combined with leflunomide.


The risk or severity of adverse effects can be increased when thalidomide is combined with spironolactone.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with methadone.


The risk or severity of adverse effects can be increased when alclometasone is combined with fleroxacin.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with memantine.


The risk or severity of adverse effects can be increased when doxycycline is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when zotepine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Bortezomib is combined with benazepril.


The risk or severity of adverse effects can be increased when equilin is combined with mefloquine.


The risk or severity of adverse effects can be increased when felodipine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when rivastigmine is combined with Varenicline.


The risk or severity of adverse effects can be increased when enflurane is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when triazolam is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when diflunisal is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when amifostine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when aspirin is combined with Mometasone.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with fexofenadine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Benidipine.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with cilnidipine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with tizanidine.


The risk or severity of adverse effects can be increased when fenoldopam is combined with furosemide.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with manidipine.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when olanzapine is combined with baclofen.


The risk or severity of adverse effects can be increased when etodolac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with cilazapril.


The risk or severity of adverse effects can be increased when olanzapine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when tropicamide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when diflunisal is combined with DEXKETOPROFEN.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when diclofenac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when diclofenac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when Olmesartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with flumethasone.


The risk or severity of adverse effects can be increased when diclofenac is combined with floctafenine.


The risk or severity of adverse effects can be increased when olanzapine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when irbesartan is combined with mesalamine.


The risk or severity of adverse effects can be increased when formestane is combined with enoxacin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when azelastine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when floctafenine is combined with diflorasone.


The risk or severity of adverse effects can be increased when triazolam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when Lurasidone is combined with clonidine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when benazepril is combined with alclofenac.


The risk or severity of adverse effects can be increased when ketorolac is combined with Naftifine.


The risk or severity of adverse effects can be increased when azelastine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when codeine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when flumethasone is combined with ambenonium.


The risk or severity of adverse effects can be increased when ketamine is combined with Asenapine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when Melatonin is combined with lithium ion.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with tetracaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Vilanterol.


The risk or severity of adverse effects can be increased when dyclonine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Butethal.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with procarbazine.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when spironolactone is combined with nadolol.


The risk or severity of adverse effects can be increased when Naftifine is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with terazosin.


The risk or severity of adverse effects can be increased when cocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Halobetasol.


The risk or severity of adverse effects can be increased when ibuprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when naratriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when zonisamide is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when prazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Vilazodone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with zotepine.


The risk or severity of adverse effects can be increased when oxybutynin is combined with TRIMETHAPHAN.


The risk or severity of adverse effects can be increased when valsartan is combined with mecamylamine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Tianeptine is combined with dobutamine.


The risk or severity of adverse effects can be increased when Normethadone is combined with furazolidone.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Efonidipine.


The risk or severity of adverse effects can be increased when tizanidine is combined with dantrolene.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Benidipine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with cilnidipine.


The risk or severity of adverse effects can be increased when flumethasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with fenbufen.


The risk or severity of adverse effects can be increased when tizanidine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with lisinopril.


The risk or severity of adverse effects can be increased when Teriflunomide is combined with fluocinonide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with mesoridazine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with maprotiline.


The risk or severity of adverse effects can be increased when zotepine is combined with triprolidine.


The risk or severity of adverse effects can be increased when zotepine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when zotepine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with desoximetasone.


The risk or severity of adverse effects can be increased when propantheline is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Conivaptan is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with MELPERONE.


The risk or severity of adverse effects can be increased when lansoprazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when chloroquine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when chloroquine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with memantine.


The risk or severity of adverse effects can be increased when ketoprofen is combined with medrysone.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when secobarbital is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Metixene is combined with buprenorphine.


The risk or severity of adverse effects can be increased when nefazodone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clonidine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when tacrolimus is combined with dexamethasone.


The risk or severity of adverse effects can be increased when flurazepam is combined with triazolam.


The risk or severity of adverse effects can be increased when triazolam is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when mepivacaine is combined with felbamate.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Olmesartan is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when griseofulvin is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when PHENPROCOUMON is combined with Nintedanib.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when benztropine is combined with tropicamide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with nicardipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with efavirenz.


The risk or severity of adverse effects can be increased when gabapentin is combined with Etidocaine.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with propoxyphene.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with diflorasone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Butethal.


The risk or severity of adverse effects can be increased when gabapentin is combined with thiothixene.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when Droxicam is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when oxazepam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when pentazocine is combined with selegiline.


The risk or severity of adverse effects can be increased when rasagiline is combined with dobutamine.


The risk or severity of adverse effects can be increased when tolnaftate is combined with felodipine.


The risk or severity of adverse effects can be increased when zaleplon is combined with chlormezanone.


The risk or severity of adverse effects can be increased when morniflumate is combined with niflumic acid.


The risk or severity of adverse effects can be increased when ketamine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when sulpiride is combined with phenytoin.


The risk or severity of adverse effects can be increased when losartan is combined with nadolol.


The risk or severity of adverse effects can be increased when flurazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when zaleplon is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Decitabine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Butethal is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when zotepine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Retigabine.


The risk or severity of adverse effects can be increased when clomipramine is combined with atenolol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with bumetanide.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Halobetasol.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with quinapril.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when hydrocortisone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with lidocaine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with clemastine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with venlafaxine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with alclofenac.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Flibanserin.


The risk or severity of adverse effects can be increased when valsartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when bupivacaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when valsartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when practolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when pentobarbital is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when Escitalopram is combined with bromocriptine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with dimethyl sulfoxide.


The risk or severity of adverse effects can be increased when halothane is combined with Riociguat.


The risk or severity of adverse effects can be increased when methadone is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when prazosin is combined with hydralazine.


The risk or severity of adverse effects can be increased when baclofen is combined with felbamate.


The risk or severity of adverse effects can be increased when sumatriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when malathion is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when fludiazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when isoflurane is combined with timolol.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with loxapine.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Remoxipride.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Isoflurophate is combined with methacholine.


The risk or severity of adverse effects can be increased when pergolide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when pergolide is combined with alprazolam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when metoprolol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when captopril is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when methadone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with penbutolol.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with barnidipine.


The risk or severity of adverse effects can be increased when clomipramine is combined with terazosin.


The risk or severity of adverse effects can be increased when quinapril is combined with Naftifine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with doxorubicin.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with phenytoin.


The risk or severity of adverse effects can be increased when floctafenine is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with triprolidine.


The risk or severity of adverse effects can be increased when Naftifine is combined with medrysone.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with methocarbamol.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with tiagabine.


The risk or severity of adverse effects can be increased when estazolam is combined with topiramate.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when fenbufen is combined with haloperidol.


The risk or severity of adverse effects can be increased when halothane is combined with tetracaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when clonidine is combined with Riociguat.


The risk or severity of adverse effects can be increased when clomipramine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with physostigmine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Spirapril.


The risk or severity of adverse effects can be increased when Nebivolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with oxymetazoline.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Eprosartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when Sacubitril is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with dipyridamole.


The risk or severity of adverse effects can be increased when ropinirole is combined with cilazapril.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Sodium aurothiomalate.


The risk or severity of adverse effects can be increased when irbesartan is combined with Salsalate.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Sacubitril.


The risk or severity of adverse effects can be increased when glutethimide is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when fluoxetine is combined with reserpine.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when sotalol is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when quetiapine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with trazodone.


The risk or severity of adverse effects can be increased when ropinirole is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when trimetrexate is combined with Benidipine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when oxycodone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with amoxapine.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Vecuronium is combined with meperidine.


The risk or severity of adverse effects can be increased when methscopolamine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when dibucaine is combined with ondansetron.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Nepafenac is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when triflupromazine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when isoflurane is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when isoflurane is combined with felodipine.


The risk or severity of adverse effects can be increased when dibucaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with baclofen.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with zonisamide.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with trandolapril.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with butorphanol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with ondansetron.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Perospirone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with tiagabine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with cocaine.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with loxapine.


The risk or severity of adverse effects can be increased when desipramine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with desipramine.


The risk or severity of adverse effects can be increased when lithium ion is combined with fludiazepam.


The risk or severity of adverse effects can be increased when fludiazepam is combined with brotizolam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with halothane.


The risk or severity of adverse effects can be increased when EDTA is combined with Deferasirox.


The risk or severity of adverse effects can be increased when brotizolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ondansetron is combined with vigabatrin.


The risk or severity of adverse effects can be increased when brotizolam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when brotizolam is combined with amoxapine.


The risk or severity of adverse effects can be increased when ondansetron is combined with benzocaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with halcinonide.


The risk or severity of adverse effects can be increased when Demecarium is combined with Varenicline.


The risk or severity of adverse effects can be increased when etodolac is combined with desoximetasone.


The risk or severity of adverse effects can be increased when amoxapine is combined with rasagiline.


The risk or severity of adverse effects can be increased when amoxapine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when hydroxyamphetamine is combined with procarbazine.


The risk or severity of adverse effects can be increased when sulpiride is combined with acetyldigitoxin.


The risk or severity of adverse effects can be increased when diltiazem is combined with irbesartan.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Etidocaine.


The risk or severity of adverse effects can be increased when buspirone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with sulpiride.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when gabapentin is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with carisoprodol.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with dantrolene.


The risk or severity of adverse effects can be increased when ketorolac is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when Nepafenac is combined with niflumic acid.


The risk or severity of adverse effects can be increased when ketorolac is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when tretinoin is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when pramipexole is combined with Sacubitril.


The risk or severity of adverse effects can be increased when pentamidine is combined with bepridil.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with enoxacin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Icatibant.


The risk or severity of adverse effects can be increased when diltiazem is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Desloratadine is combined with levodopa.


The risk or severity of adverse effects can be increased when flurazepam is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when flurazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when Tapentadol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when flurazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when flurazepam is combined with quazepam.


The risk or severity of adverse effects can be increased when Milnacipran is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when barnidipine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with enoxacin.


The risk or severity of adverse effects can be increased when isradipine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with loratadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with betaxolol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when ketamine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when benzocaine is combined with citalopram.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with tetracaine.


The risk or severity of adverse effects can be increased when Torasemide is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Torasemide is combined with methazolamide.


The risk or severity of adverse effects can be increased when benazepril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when Artemether is combined with felodipine.


The risk or severity of adverse effects can be increased when benazepril is combined with Salsalate.


The risk or severity of adverse effects can be increased when perphenazine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with bromocriptine.


The risk or severity of adverse effects can be increased when temazepam is combined with levorphanol.


The risk or severity of adverse effects can be increased when Perospirone is combined with flunarizine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Tramadol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when timolol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with enflurane.


The risk or severity of adverse effects can be increased when betaxolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with difluprednate.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with cinnarizine.


The risk or severity of adverse effects can be increased when oxazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when oxazepam is combined with pimozide.


The risk or severity of adverse effects can be increased when meperidine is combined with nalbuphine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with bromazepam.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when propoxyphene is combined with furosemide.


The risk or severity of adverse effects can be increased when meperidine is combined with oxazepam.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with bromazepam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Retigabine.


The risk or severity of adverse effects can be increased when thiopental is combined with Difenoxin.


The risk or severity of adverse effects can be increased when apomorphine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with penbutolol.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with lithium ion.


The risk or severity of adverse effects can be increased when propoxyphene is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when apomorphine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when apomorphine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Butethal.


The risk or severity of adverse effects can be increased when benazepril is combined with felodipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with methazolamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with perphenazine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Eplerenone is combined with indapamide.


The risk or severity of adverse effects can be increased when oxazepam is combined with levorphanol.


The risk or severity of adverse effects can be increased when oxymorphone is combined with indapamide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with cocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with glutethimide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with proparacaine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Halazepam.


The risk or severity of adverse effects can be increased when enflurane is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with amobarbital.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with dantrolene.


The risk or severity of adverse effects can be increased when clozapine is combined with zonisamide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Butethal.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Agomelatine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when clozapine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with mesalamine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with zonisamide.


The risk or severity of adverse effects can be increased when thioridazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with lisinopril.


The risk or severity of adverse effects can be increased when tolmetin is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when Tramadol is combined with metolazone.


The risk or severity of adverse effects can be increased when Tramadol is combined with dibucaine.


The risk or severity of adverse effects can be increased when butamben is combined with topiramate.


The risk or severity of adverse effects can be increased when oxycodone is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with ROSOXACIN.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with tiagabine.


The risk or severity of adverse effects can be increased when paroxetine is combined with reserpine.


The risk or severity of adverse effects can be increased when isoflurane is combined with amoxapine.


The risk or severity of adverse effects can be increased when midodrine is combined with dopamine.


The risk or severity of adverse effects can be increased when carprofen is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when isoflurane is combined with thiamylal.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when barnidipine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when bepridil is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when cetirizine is combined with imipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when cetirizine is combined with loratadine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with quetiapine.


The risk or severity of adverse effects can be increased when Eletriptan is combined with clomipramine.


The risk or severity of adverse effects can be increased when alclometasone is combined with Isoflurophate.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ethotoin.


The risk or severity of adverse effects can be increased when trimipramine is combined with clonazepam.


The risk or severity of adverse effects can be increased when alclometasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when temazepam is combined with diphenhydramine.


The risk or severity of adverse effects can be increased when trimipramine is combined with isoproterenol.


The risk or severity of adverse effects can be increased when morphine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when morphine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when zopiclone is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when CAPECITABINE is combined with leflunomide.


The risk or severity of adverse effects can be increased when indomethacin is combined with etodolac.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when indomethacin is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when mecamylamine is combined with Pentolinium.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with acebutolol.


The risk or severity of adverse effects can be increased when indomethacin is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when clorazepate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with minoxidil.


The risk or severity of adverse effects can be increased when chlormezanone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with fenoprofen.


The risk or severity of adverse effects can be increased when Sacubitril is combined with quetiapine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when cetirizine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when tiagabine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cetirizine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when ganciclovir is combined with stavudine.


The risk or severity of adverse effects can be increased when zopiclone is combined with tizanidine.


The risk or severity of adverse effects can be increased when Vorapaxar is combined with argatroban.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with scopolamine.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Tapentadol.


The risk or severity of adverse effects can be increased when tropicamide is combined with Normethadone.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with efavirenz.


The risk or severity of adverse effects can be increased when gabapentin is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Olsalazine is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when amitriptyline is combined with promethazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when levodopa is combined with Pizotifen.


The risk or severity of adverse effects can be increased when amitriptyline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when irbesartan is combined with Propacetamol.


The risk or severity of adverse effects can be increased when tirofiban is combined with mesalamine.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with oxycodone.


The risk or severity of adverse effects can be increased when iodixanol is combined with metformin.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with diflunisal.


The risk or severity of adverse effects can be increased when quinapril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when carbamazepine is combined with procaine.


The risk or severity of adverse effects can be increased when butorphanol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when butorphanol is combined with lithium ion.


The risk or severity of adverse effects can be increased when butorphanol is combined with amobarbital.


The risk or severity of adverse effects can be increased when butorphanol is combined with Butethal.


The risk or severity of adverse effects can be increased when zonisamide is combined with duloxetine.


The risk or severity of adverse effects can be increased when lorazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when zopiclone is combined with dibucaine.


The risk or severity of adverse effects can be increased when zonisamide is combined with fluoxetine.


The risk or severity of adverse effects can be increased when diltiazem is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when clorazepate is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when tiagabine is combined with felbamate.


The risk or severity of adverse effects can be increased when docetaxel is combined with Vinflunine.


The risk or severity of adverse effects can be increased when etizolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when dibucaine is combined with thiopental.


The risk or severity of adverse effects can be increased when imipramine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when duloxetine is combined with sulpiride.


The risk or severity of adverse effects can be increased when oxprenolol is combined with methazolamide.


The risk or severity of adverse effects can be increased when imipramine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when resveratrol is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when amitriptyline is combined with doxepin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Sacubitril is combined with valsartan.


The risk or severity of adverse effects can be increased when imipramine is combined with trimipramine.


The risk or severity of adverse effects can be increased when selegiline is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when chlormezanone is combined with vigabatrin.


The risk or severity of adverse effects can be increased when butabarbital is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when selegiline is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when selegiline is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Remoxipride is combined with proparacaine.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Telmisartan is combined with trandolapril.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Halazepam.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with oxprenolol.


The risk or severity of adverse effects can be increased when lisinopril is combined with niflumic acid.


The risk or severity of adverse effects can be increased when oxazepam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with buprenorphine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when Olsalazine is combined with flumethasone.


The risk or severity of adverse effects can be increased when meprobamate is combined with nefazodone.


The risk or severity of adverse effects can be increased when diazepam is combined with Asenapine.


The risk or severity of adverse effects can be increased when meprobamate is combined with doxepin.


The risk or severity of adverse effects can be increased when amitriptyline is combined with methadone.


The risk or severity of adverse effects can be increased when tiagabine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with selegiline.


The risk or severity of adverse effects can be increased when docetaxel is combined with 4-Methoxyphenol.


The risk or severity of adverse effects can be increased when bepridil is combined with quetiapine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with topiramate.


The risk or severity of adverse effects can be increased when ATROPINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when celecoxib is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Tapentadol is combined with procarbazine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Pizotifen.


The risk or severity of adverse effects can be increased when felodipine is combined with terazosin.


The risk or severity of adverse effects can be increased when thalidomide is combined with D-mannitol.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with propofol.


The risk or severity of adverse effects can be increased when nortriptyline is combined with maprotiline.


The risk or severity of adverse effects can be increased when Fospropofol is combined with cetirizine.


The risk or severity of adverse effects can be increased when epoprostenol is combined with halothane.


The risk or severity of adverse effects can be increased when Eprosartan is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Fospropofol is combined with protriptyline.


The risk or severity of adverse effects can be increased when alclofenac is combined with halcinonide.


The risk or severity of adverse effects can be increased when alclofenac is combined with difluprednate.


The risk or severity of adverse effects can be increased when bifonazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with amoxapine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with nortriptyline.


The risk or severity of adverse effects can be increased when prilocaine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when tolmetin is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when tolmetin is combined with Deferasirox.


The risk or severity of adverse effects can be increased when celecoxib is combined with salicylic acid.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with bumetanide.


The risk or severity of adverse effects can be increased when resveratrol is combined with betamethasone.


The risk or severity of adverse effects can be increased when Lofexidine is combined with ropinirole.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with Aliskiren.


The risk or severity of adverse effects can be increased when reserpine is combined with flunarizine.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when timolol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when aminophylline is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when thiopental is combined with fluoxetine.


The risk or severity of adverse effects can be increased when thiopental is combined with duloxetine.


The risk or severity of adverse effects can be increased when morphine is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when timolol is combined with Metipranolol.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with reserpine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with D-mannitol.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with triprolidine.


The risk or severity of adverse effects can be increased when estazolam is combined with Normethadone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with methocarbamol.


The risk or severity of adverse effects can be increased when midazolam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when midazolam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Demecarium.


The risk or severity of adverse effects can be increased when Clofarabine is combined with tizanidine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Darunavir.


The risk or severity of adverse effects can be increased when tropicamide is combined with levorphanol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Tianeptine is combined with pargyline.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when imipramine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when brimonidine is combined with sertraline.


The risk or severity of adverse effects can be increased when clemastine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when nefazodone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when amsacrine is combined with leflunomide.


The risk or severity of adverse effects can be increased when butalbital is combined with ethotoin.


The risk or severity of adverse effects can be increased when indomethacin is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when butalbital is combined with prilocaine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with etodolac.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when lidocaine is combined with dyclonine.


The risk or severity of adverse effects can be increased when olanzapine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Arotinolol is combined with trandolapril.


The risk or severity of adverse effects can be increased when tenoxicam is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when mesalamine is combined with Deferasirox.


The risk or severity of adverse effects can be increased when midazolam is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Estrone sulfate is combined with decamethonium.


The risk or severity of adverse effects can be increased when tacrolimus is combined with 6-Mercaptopurine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when midazolam is combined with bromazepam.


The risk or severity of adverse effects can be increased when pentobarbital is combined with butalbital.


The risk or severity of adverse effects can be increased when methysergide is combined with clindamycin.


The risk or severity of adverse effects can be increased when LEVOSIMENDAN is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when trazodone is combined with felbamate.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when mesoridazine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when methylprednisolone is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when nisoldipine is combined with sotalol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when salicylic acid is combined with cinnarizine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when ambenonium is combined with acetylcholine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with bumetanide.


The risk or severity of adverse effects can be increased when diflunisal is combined with Mometasone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with 5-azacytidine.


The risk or severity of adverse effects can be increased when butalbital is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Riociguat.


The risk or severity of adverse effects can be increased when butalbital is combined with clemastine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Articaine is combined with clemastine.


The risk or severity of adverse effects can be increased when Articaine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when pimozide is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when methysergide is combined with vinblastine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with ethotoin.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with prilocaine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with nefazodone.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with cinoxacin.


The risk or severity of adverse effects can be increased when halothane is combined with penbutolol.


The risk or severity of adverse effects can be increased when carisoprodol is combined with doxepin.


The risk or severity of adverse effects can be increased when azelastine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when prilocaine is combined with proparacaine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with niflumic acid.


The risk or severity of adverse effects can be increased when lorazepam is combined with clonidine.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Carfilzomib.


The risk or severity of adverse effects can be increased when proparacaine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with Olopatadine.


The risk or severity of adverse effects can be increased when promethazine is combined with clomipramine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with ANISOTROPINE METHYLBROMIDE.


The risk or severity of adverse effects can be increased when Miltefosine is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when dapsone is combined with phenobarbital.


The risk or severity of adverse effects can be increased when amphotericin b is combined with labetalol.


The risk or severity of adverse effects can be increased when propofol is combined with dantrolene.


The risk or severity of adverse effects can be increased when Articaine is combined with ethotoin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when oxaprozin is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when amphotericin b is combined with doxazosin.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with betaxolol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with amitriptyline.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with malathion.


The risk or severity of adverse effects can be increased when Flupentixol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when MOXONIDINE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with chlormezanone.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with Perospirone.


The risk or severity of adverse effects can be increased when procaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when Spirapril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when procaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Spirapril is combined with Salsalate.


The risk or severity of adverse effects can be increased when mirtazapine is combined with periciazine.


The risk or severity of adverse effects can be increased when quetiapine is combined with Normethadone.


The risk or severity of adverse effects can be increased when Boceprevir is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when prazepam is combined with duloxetine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Escitalopram.


The risk or severity of adverse effects can be increased when thioridazine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with flunarizine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with baclofen.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with oxycodone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Imatinib.


The risk or severity of adverse effects can be increased when morphine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Fospropofol.


The risk or severity of adverse effects can be increased when morphine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when amifostine is combined with tretinoin.


The risk or severity of adverse effects can be increased when amifostine is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when amifostine is combined with isoflurane.


The risk or severity of adverse effects can be increased when lisinopril is combined with tenoxicam.


The risk or severity of adverse effects can be increased when lisinopril is combined with ketorolac.


The risk or severity of adverse effects can be increased when butalbital is combined with desipramine.


The risk or severity of adverse effects can be increased when lisinopril is combined with nabumetone.


The risk or severity of adverse effects can be increased when Icatibant is combined with budesonide.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with Icatibant.


The risk or severity of adverse effects can be increased when isoflurane is combined with brotizolam.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with ILOPROST.


The risk or severity of adverse effects can be increased when risperidone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when flunisolide is combined with mefloquine.


The risk or severity of adverse effects can be increased when Posaconazole is combined with Pregabalin.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with paroxetine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when hexetidine is combined with Amrinone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Perospirone.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when tioconazole is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with terbutaline.


The risk or severity of adverse effects can be increased when rasagiline is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with Flupentixol.


The risk or severity of adverse effects can be increased when metolazone is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when epoprostenol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when trandolapril is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Etomidate is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when imipramine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when trandolapril is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with sulpiride.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with digoxin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Perospirone.


The risk or severity of adverse effects can be increased when estazolam is combined with Lurasidone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with brotizolam.


The risk or severity of adverse effects can be increased when ANISOTROPINE METHYLBROMIDE is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when azelastine is combined with Salsalate.


The risk or severity of adverse effects can be increased when azelastine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Normethadone.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with nadolol.


The risk or severity of adverse effects can be increased when cabergoline is combined with methadone.


The risk or severity of adverse effects can be increased when valsartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Butethal is combined with amisulpride.


The risk or severity of adverse effects can be increased when valsartan is combined with fenbufen.


The risk or severity of adverse effects can be increased when prazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when cabergoline is combined with olanzapine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when Butethal is combined with HEROIN.


The risk or severity of adverse effects can be increased when pramipexole is combined with sotalol.


The risk or severity of adverse effects can be increased when cabergoline is combined with omeprazole.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with tofisopam.


The risk or severity of adverse effects can be increased when Lacidipine is combined with Sacubitril.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when vigabatrin is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when mirtazapine is combined with rizatriptan.


The risk or severity of adverse effects can be increased when mirtazapine is combined with naratriptan.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when isoflurane is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when ethanol is combined with zopiclone.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Butethal.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when phenmetrazine is combined with terbutaline.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with lithium ion.


The risk or severity of adverse effects can be increased when cabergoline is combined with Sitaxsentan.


The risk or severity of adverse effects can be increased when enalapril is combined with resveratrol.


The risk or severity of adverse effects can be increased when morphine is combined with meclizine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with butamben.


The risk or severity of adverse effects can be increased when Vilazodone is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when cocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Halazepam.


The risk or severity of adverse effects can be increased when cocaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when procaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Clobetasone.


The risk or severity of adverse effects can be increased when procaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when ifosfamide is combined with clozapine.


The risk or severity of adverse effects can be increased when flunisolide is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when lorazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when enalapril is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when oxycodone is combined with procaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with niflumic acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when triprolidine is combined with felbamate.


The risk or severity of adverse effects can be increased when Halobetasol is combined with decamethonium.


The risk or severity of adverse effects can be increased when methscopolamine is combined with methadone.


The risk or severity of adverse effects can be increased when triazolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when thiothixene is combined with MELPERONE.


The risk or severity of adverse effects can be increased when lisinopril is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when lisinopril is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when lorazepam is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when mesoridazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when lisinopril is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when epinephrine is combined with methoxamine.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when lisinopril is combined with Droxicam.


The risk or severity of adverse effects can be increased when trandolapril is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Lurasidone is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when amoxapine is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when Icatibant is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when amobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with sulpiride.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when bupivacaine is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when loxapine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when loxapine is combined with Halazepam.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with physostigmine.


The risk or severity of adverse effects can be increased when loxapine is combined with proparacaine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when azelastine is combined with betamethasone.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when celecoxib is combined with Propacetamol.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when irbesartan is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with thiopental.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with haloperidol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Pipamperone.


The risk or severity of adverse effects can be increased when trazodone is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with ethosuximide.


The risk or severity of adverse effects can be increased when trimethoprim is combined with amantadine.


The risk or severity of adverse effects can be increased when tacrolimus is combined with doxorubicin.


The risk or severity of adverse effects can be increased when butorphanol is combined with felbamate.


The risk or severity of adverse effects can be increased when Droxicam is combined with Clobetasone.


The risk or severity of adverse effects can be increased when benzocaine is combined with etizolam.


The risk or severity of adverse effects can be increased when Naftifine is combined with suprofen.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with nicardipine.


The risk or severity of adverse effects can be increased when codeine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Naftifine is combined with alclometasone.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when cyclopentolate is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Naftifine.


The risk or severity of adverse effects can be increased when propofol is combined with mesoridazine.


The risk or severity of adverse effects can be increased when propofol is combined with maprotiline.


The risk or severity of adverse effects can be increased when quetiapine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when trihexyphenidyl is combined with morphine.


The risk or severity of adverse effects can be increased when clozapine is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when celecoxib is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when timolol is combined with benazepril.


The risk or severity of adverse effects can be increased when enalapril is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when dopamine is combined with nylidrin.


The risk or severity of adverse effects can be increased when prednisone is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when AZILSARTAN MEDOXOMIL is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when butabarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when imipramine is combined with celiprolol.


The risk or severity of adverse effects can be increased when isoflurane is combined with Pizotifen.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with triamterene.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when zaleplon is combined with Olopatadine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with eperisone.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Olsalazine.


The risk or severity of adverse effects can be increased when bepridil is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when promazine is combined with butamben.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when labetalol is combined with isoproterenol.


The risk or severity of adverse effects can be increased when selegiline is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with quinapril.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when ropinirole is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when imipramine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ropinirole is combined with tolazoline.


The risk or severity of adverse effects can be increased when ketamine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when carbamazepine is combined with meclizine.


The risk or severity of adverse effects can be increased when tropicamide is combined with methadone.


The risk or severity of adverse effects can be increased when Fospropofol is combined with efavirenz.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with DESONIDE.


The risk or severity of adverse effects can be increased when propofol is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Normethadone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when indapamide is combined with OXCARBAZEPINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when procaine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when cabergoline is combined with manidipine.


The risk or severity of adverse effects can be increased when secobarbital is combined with Butethal.


The risk or severity of adverse effects can be increased when secobarbital is combined with amobarbital.


The risk or severity of adverse effects can be increased when Isoconazole is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when meperidine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with enflurane.


The risk or severity of adverse effects can be increased when Amrinone is combined with MAGNESIUM HYDROXIDE.


The risk or severity of adverse effects can be increased when thiamylal is combined with cetirizine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when protriptyline is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Droxicam is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when pentazocine is combined with phenobarbital.


The risk or severity of adverse effects can be increased when chloroquine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Olaparib.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Palbociclib.


The risk or severity of adverse effects can be increased when benzocaine is combined with felbamate.


The risk or severity of adverse effects can be increased when pentazocine is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Caspofungin is combined with xylometazoline.


The risk or severity of adverse effects can be increased when bromocriptine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when biperiden is combined with methscopolamine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Mometasone.


The risk or severity of adverse effects can be increased when clorazepate is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with difluprednate.


The risk or severity of adverse effects can be increased when tretinoin is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when benzocaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when chloroxine is combined with felodipine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Efonidipine.


The risk or severity of adverse effects can be increased when pentazocine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when methazolamide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when dyclonine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when phenobarbital is combined with triprolidine.


The risk or severity of adverse effects can be increased when pentazocine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when chloroxine is combined with cilnidipine.


The risk or severity of adverse effects can be increased when oxycodone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when pentazocine is combined with thiopental.


The risk or severity of adverse effects can be increased when chloroxine is combined with manidipine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with amcinonide.


The risk or severity of adverse effects can be increased when chloroquine is combined with prednisone.


The risk or severity of adverse effects can be increased when dibucaine is combined with Oxybuprocaine.